Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2019: $0; 2018: $71)	$ 2,823	$ 2,724
Marketable securities	11	100
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2019: $49; 2018: $42)	5,125	5,646
Other	3,683	3,389
Inventories	6,416	6,899
Other current assets	891	712
Assets of discontinued operations - current	0	19,900
Total current assets	18,949	39,370
Investments
Investment in nonconsolidated affiliates	3,007	3,320
Other investments (investments carried at fair value - 2019: $0; 2018: $1,699)	2,737	2,646
Noncurrent receivables	881	360
Total investments	6,625	6,326
Property
Property	54,890	53,984
Less accumulated depreciation	33,887	32,566
Net property (variable interest entities restricted - 2019: $0; 2018: $683)	21,003	21,418
Other Assets
Goodwill	9,785	9,846
Other intangible assets (net of accumulated amortization - 2019: $0; 2018: $3,379)	3,859	4,225
Operating lease right-of-use assets	2,130	0
Deferred income tax assets	1,765	1,779
Deferred charges and other assets	821	735
Total other assets	18,360	16,585
Total Assets	64,937	83,699
Current Liabilities
Notes payable	517	298
Long-term debt due within one year	378	338
Accounts payable:
Trade	3,855	4,456
Other	2,025	2,479
Operating lease liabilities - current	418	0
Income taxes payable	490	557
Accrued and other current liabilities	3,518	2,931
Liabilities of discontinued operations - current	0	4,488
Total current liabilities	11,201	15,547
Long-Term Debt (variable interest entities nonrecourse - 2019: $0; 2018: $75)	17,213	19,253
Other Noncurrent Liabilities
Deferred income tax liabilities	380	501
Pension and other postretirement benefits - noncurrent	8,447	8,926
Asbestos-related liabilities - noncurrent	1,087	1,142
Operating lease liabilities - noncurrent	1,735	0
Other noncurrent obligations	6,888	4,709
Total other noncurrent liabilities	18,537	15,278
Stockholder's Equity
Common stock (authorized and issued 100 shares of $0.01 par value each)	7	0
Additional paid-in capital	7,239	7,042
Retained earnings	19,873	35,460
Accumulated other comprehensive loss	(9,219)	(9,885)
Unearned ESOP shares	(95)	(134)
The Dow Chemical Company’s stockholder's equity	17,399	32,483
Noncontrolling interests	587	1,138
Total equity	17,986	33,621
Total Liabilities and Equity	64,937	83,699
The Dow Chemical Company [Domain]
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2019: $0; 2018: $71)	2,823	2,724
Marketable securities	11	100
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2019: $49; 2018: $42)	5,125	5,646
Other	3,687	3,389
Inventories	6,416	6,899
Other current assets	774	712
Assets of discontinued operations - current	0	19,900
Total current assets	18,836	39,370
Investments
Investment in nonconsolidated affiliates	3,007	3,320
Other investments (investments carried at fair value - 2019: $0; 2018: $1,699)	2,737	2,646
Noncurrent receivables	868	360
Total investments	6,612	6,326
Property
Property	54,890	53,984
Less accumulated depreciation	33,887	32,566
Net property (variable interest entities restricted - 2019: $0; 2018: $683)	21,003	21,418
Other Assets
Goodwill	9,785	9,846
Other intangible assets (net of accumulated amortization - 2019: $0; 2018: $3,379)	3,859	4,225
Operating lease right-of-use assets	2,130	0
Deferred income tax assets	1,765	1,779
Deferred charges and other assets	820	735
Total other assets	18,359	16,585
Total Assets	64,810	83,699
Current Liabilities
Notes payable	935	298
Long-term debt due within one year	378	338
Accounts payable:
Trade	3,855	4,456
Other	2,025	2,479
Operating lease liabilities - current	418	0
Income taxes payable	490	557
Accrued and other current liabilities	3,145	2,931
Liabilities of discontinued operations - current	0	4,488
Total current liabilities	11,246	15,547
Long-Term Debt (variable interest entities nonrecourse - 2019: $0; 2018: $75)	17,213	19,253
Other Noncurrent Liabilities
Deferred income tax liabilities	380	501
Pension and other postretirement benefits - noncurrent	8,447	8,926
Asbestos-related liabilities - noncurrent	1,087	1,142
Operating lease liabilities - noncurrent	1,735	0
Other noncurrent obligations	6,335	4,709
Total other noncurrent liabilities	17,984	15,278
Stockholder's Equity
Common stock (authorized and issued 100 shares of $0.01 par value each)	0	0
Additional paid-in capital	7,245	7,042
Retained earnings	19,849	35,460
Accumulated other comprehensive loss	(9,219)	(9,885)
Unearned ESOP shares	(95)	(134)
The Dow Chemical Company’s stockholder's equity	17,780	32,483
Noncontrolling interests	587	1,138
Total equity	18,367	33,621
Total Liabilities and Equity	$ 64,810	$ 83,699